文献速递神经创伤神经重症

创伤性脑损伤去骨瓣减压术后颅骨修补最佳时机:系统评价、荟萃分析与进行中试验概览

Optimal timing of cranioplasty post-decompressive craniectomy in traumatic brain injury: a systematic review, meta-analysis, and overview of ongoing trials.
PubMed 文献 · Acta Neurochir (Wien) · 2026-01-08

总体并发症无差异,但自体/异体材料早期修补并发症风险更高(RR=1.92),混合材料早期再手术风险更高(RR=2.98);超早期(<35天)术后脑积水风险更低(RR=0.31),手术时间更短(MD=-23.94分钟)。结论认为修补时机本身不决定安全性与疗效,风险因植入材料而异。

要点

  • 早期与晚期颅骨修补总体并发症无差异,但风险因植入材料显著不同。
  • 自体或异体材料早期修补并发症风险增高(RR=1.92),混合材料早期再手术风险增高(RR=2.98)。
  • 超早期(<35天)修补术后脑积水风险更低(RR=0.31),手术时间更短。

核心结论

  • 颅骨修补时机本身不决定安全性与疗效,风险因植入材料和围手术期情况显著不同。
  • 超早期修补可能带来手术和生理优势且不增加感染或死亡,尤其使用合成材料时。
  • 早期自体或异体材料再植入并发症和再手术风险更高。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE、Embase和CENTRAL从建库至2025年4月,辅以手工筛选和灰色文献。
  • 纳入比较成人创伤性脑损伤去骨瓣减压术后早期(≤90天)与晚期(>90天)颅骨修补的随机和观察性研究。

主要发现

  • 早期与晚期修补总体并发症无差异,但自体/异体材料早期修补并发症风险更高(RR=1.92;P=0.02)。
  • 混合材料早期修补再手术风险显著更高(RR=2.98;P=0.02),功能结局无差异。
  • 超早期修补术后脑积水风险更低(RR=0.31;P=0.005),分流依赖无显著差异。
  • 早期修补手术时间更短(MD=-23.94分钟;P=0.0008),超早期缩短最明显(MD=-42.43分钟;P<0.00001)。
  • 硬膜外积液、感染、血肿、骨吸收、癫痫或死亡率均无显著差异。

关键数值与推荐

  • 早期颅骨修补定义为≤90天,晚期定义为>90天,超早期定义为<35天。
  • 主要结局为总体并发症、再手术和功能结局;次要结局包括脑积水、分流依赖、硬膜外积液、感染、血肿、骨吸收、癫痫、死亡率和手术时间。

临床怎么用

  • 不应简单以早期或晚期二分法决策,应结合植入材料和患者具体情况制定个体化修补策略。
  • 使用合成材料时可考虑超早期修补,可能缩短手术时间且不增加感染或死亡风险。
  • 早期使用自体或异体材料再植入需谨慎评估并发症和再手术风险。

局限性

  • 证据主要基于观察性数据,证据确定性为低至中等,解释需谨慎。
  • 研究间时间阈值不一致,且对植入材料等效应修饰因素关注有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal timing of cranioplasty (CP) following decompressive craniectomy (DC) for the management of traumatic brain injury (TBI) remains debated. Prior studies comparing early CP (EC) and late CP (LC) report conflicting outcomes, compounded by inconsistent timing thresholds and limited attention to effect modifiers such as implant material. OBJECTIVE: To perform a systematic review and meta-analysis comparing outcomes of EC (≤ 90 days) versus LC (> 90 days) after DC for TBI, with particular evaluation of ultra-EC (< 35 days) and implant material. METHODS: MEDLINE, Embase, and CENTRAL were electronically searched from inception to April 2025, supplemented by manual screening of references and grey literature. Randomised and observational studies comparing EC and LC in adult TBI patients were included. Primary outcomes of interest were overall complications, reoperation, and functional outcomes. Secondary outcomes included hydrocephalus, shunt dependence, extra-axial collections, infection, haematoma, bone resorption, seizures, mortality, and operative time. Risk of bias was assessed with ROBINS-I and RoB 2 tools, and certainty of evidence with GRADE. Pooled risk ratios (RRs) and mean differences (MDs) were calculated using random-effects meta-analysis. RESULTS: Eighteen studies (n = 2226) were included. Overall complications did not differ between EC and LC, though autologous/allogenic EC carried higher risk (RR = 1.92; P = 0.02). Reoperation was significantly higher in mixed-materials EC cohorts (RR = 2.98; P = 0.02). No difference was observed in functional outcomes. Ultra-EC was associated with a lower risk of postoperative hydrocephalus (RR = 0.31; P = 0.005), while shunt dependence showed no significant difference. No significant differences were observed in extra-axial collections, infection, haematoma, bone resorption, seizures, or mortality. Operative time was shorter with EC (MD = -23.94 min; P = 0.0008), with the greatest reductions in ultra-EC (MD = -42.43 min; P < 0.00001). These findings are based largely on observational data with low-moderate certainty and should be interpreted cautiously. CONCLUSIONS: CP timing alone does not determine safety or efficacy, with risks varying substantially by implant material. Outcomes are critically modified by implant material and perioperative context. Ultra-EC may confer operative and physiological advantages without excess infection or mortality, particularly with synthetic implants, whereas early autologous or allogenic reimplantation carries higher risk of complications and reoperations. These findings argue for moving beyond a simplistic early-versus-late dichotomy and instead shifting towards material- and patient-specific strategies. Harmonised definitions and material-stratified prospective trials incorporating long-term functional outcomes are essential to establish evidence-based guidelines.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Thamilmaran A, Patel S, Nischal SA, et al. Optimal timing of cranioplasty post-decompressive craniectomy in traumatic brain injury: a systematic review, meta-analysis, and overview of ongoing trials. Acta Neurochir (Wien). 2026. PMID: 41507542. doi:10.1007/s00701-025-06759-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。